Image Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects 22/03/2017 En savoir plus sur Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects
Image Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission 17/03/2017 En savoir plus sur Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission
Image Proceedings of Réanimation 2017, the French Intensive Care Society International Congress 10/01/2017 En savoir plus sur Proceedings of Réanimation 2017, the French Intensive Care Society International Congress
Image Proceedings of Réanimation 2017, the French Intensive Care Society International Congress 10/01/2017 En savoir plus sur Proceedings of Réanimation 2017, the French Intensive Care Society International Congress
Image Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis 04/01/2017 En savoir plus sur Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis
Image Reappraisal of visiting policies and procedures of patient’s family information in 188 French ICUs: a report of the Outcomerea Research Group 26/08/2016 En savoir plus sur Reappraisal of visiting policies and procedures of patient’s family information in 188 French ICUs: a report of the Outcomerea Research Group
Image Treatment intensity and outcome of nonagenarians selected for admission in ICUs: a multicenter study of the Outcomerea Research Group 14/04/2016 En savoir plus sur Treatment intensity and outcome of nonagenarians selected for admission in ICUs: a multicenter study of the Outcomerea Research Group
Image Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study 08/01/2016 En savoir plus sur Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study